Melrose Health’s new longevity-focused supplements address decreasing health span, increasing chronic disease incidence in Australia
“As longevity relates to a combination of health span and lifespan, it is gaining a tremendous amount of attention due to Australia’s ageing population in addition to the nation’s growing incidence of chronic disease.
“As the average life expectancy increases, we know that we are living longer, however the last 10 to 15 years of our existence are negatively impacted by chronic disease, which can be linked back to poor lifestyle choices. As a result, Australians are very interested in evidence-based interventions that will improve the quality of their life as they age,” Nathan Cheong, Chief Executive Officer of Melrose, told NutraIngredients-Asia.
The firm believes that the most important variable underpinning how people age is metabolic health, a complex process through which the body converts food and drink into energy.
“Metabolism typically slows down with age. It can also be affected by a lack of exercise and overconsumption of ultra-processed foods, which in turn impact weight management and overall energy level.
“Poor metabolic function is the cause of many age-related conditions, including neurodegenerative disease, cardiovascular disease, and the spectrum of diabetes-related disorders,” said Melrose’s Chief Marketing Officer, Michael Davies.
One of Future Lab’s key products, Berberine Complex, claims to help regulate metabolism and energy balance in the body via activation of an enzyme called adenosine monophosphate-activated protein kinase (AMPK).
By activating AMPK, berberine can enhance glucose uptake in cells, promote insulin sensitivity, and support the breakdown of fats for energy.
Another noteworthy product is NAD Booster, which elevates NAD+ (nicotinamide adenine dinucleotide) levels through nicotinamide riboside.
“NAD+ plays a crucial role in various metabolic processes within our cells. NAD+ levels tend to decline as we age, which can negatively impact cellular functions, including DNA repair, energy production, and regulation of circadian rhythms. Raising NAD+ levels through Future Lab NAD Booster may help support healthy ageing by promoting cellular health.”
The second phase, set for release in the second half of 2024, will focus on perimenopause and menopause, methylation, omega-3 fatty acid production, male hormone regulation, and collagen formation.
Source link
Share this article:












